Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|September 15, 2007
DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replicationYasuo Ariumi, Misao Kuroki, Ken-ichi Abe, et al.
Virus Research|July 8, 2008
A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replicationHiromichi Dansako, Masanori Ikeda, Ken-ichi Abe, et al.
Journal of Hepatology|March 21, 2006
Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cellsKazuhito Naka, Ken-ichi Abe, Kazunori Takemoto, et al.
The Journal of General Virology|September 28, 2005
Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptorsKazuhito Naka, Kazunori Takemoto, Ken-Ichi Abe, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2007
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell cultureMasahiko Yano, Masanori Ikeda, Ken-Ichi Abe, et al.
Plos Pathogens|May 30, 2013
Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cellsHiromichi Dansako, Daisuke Yamane, Christoph Welsch, et al.
Archives of Virology|December 14, 2019
Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell cultureNobuyuki Kato, Youki Ueda, Hiroe Sejima, et al.
Biochemical and Biophysical Research Communications|September 8, 2004
Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotypeKatsuyuki Namba, Kazuhito Naka, Hiromichi Dansako, et al.
The FEBS Journal|October 17, 2015
The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assemblyHiromichi Dansako, Youki Ueda, Nobuaki Okumura, et al.
Cancer Science|February 10, 2023
Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunityTomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Pageof 8